Tomáš Smutný
- Molecular Biology
- Pharmacology top 2%
- Oncology
- Organic Chemistry
- Endocrinology, Diabetes and Metabolism top 10%
- Co-authors
- Petr PávekSridhar ManiAlejandro CarazoFrantišek TrejtnarJán DušekZdeněk DvořákKateřina VávrováAlexandr Hrabálek
- Topics
- Pharmacogenetics and Drug Metabolism (21 papers)Drug Transport and Resistance Mechanisms (12 papers)Hormonal Regulation and Hypertension (7 papers)
In The Last Decade
Tomáš Smutný
32 papers receiving 697 citations
Peers
Comparison fields: 5 of 88
- Molecular Biology 224
- Pharmacology 219
- Oncology 162
- Organic Chemistry 126
- Endocrinology, Diabetes and Metabolism 100
Countries citing papers authored by Tomáš Smutný
This map shows the geographic impact of Tomáš Smutný's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomáš Smutný with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomáš Smutný more than expected).
Fields of papers citing papers by Tomáš Smutný
This network shows the impact of papers produced by Tomáš Smutný. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomáš Smutný. The network helps show where Tomáš Smutný may publish in the future.
Co-authorship network of co-authors of Tomáš Smutný
This figure shows the co-authorship network connecting the top 25 collaborators of Tomáš Smutný. A scholar is included among the top collaborators of Tomáš Smutný based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomáš Smutný. Tomáš Smutný is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 3 | |
| 4 | 13 | |
| 5 | 2 | |
| 6 | 5 | |
| 7 | 7 | |
| 8 | 3 | |
| 9 | 4 | |
| 10 | 23 | |
| 11 | 37 | |
| 12 | 6 | |
| 13 | 17 | |
| 14 | 21 | |
| 15 | 16 | |
| 16 | 55 | |
| 17 | 46 | |
| 18 | 11 | |
| 19 | 29 | |
| 20 | 25 |
About Tomáš Smutný
Tomáš Smutný is a scholar working on Pharmacology, Physiology and Oncology, having authored 33 papers that have together received 710 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (21 papers), Drug Transport and Resistance Mechanisms (12 papers) and Hormonal Regulation and Hypertension (7 papers). The work is most often cited by research in Pharmacology (219 citations), Biochemistry (45 citations) and Endocrinology, Diabetes and Metabolism (100 citations). Tomáš Smutný has collaborated with scholars based in Czechia, Finland and Germany. Frequent co-authors include Petr Pávek, Sridhar Mani, Alejandro Carazo, František Trejtnar, Ján Dušek, Zdeněk Dvořák, Kateřina Vávrová, Alexandr Hrabálek, Věra Klimešová and Jaroslav Roh. Their work appears in journals such as Biomaterials, International Journal of Molecular Sciences and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.